Search clinical trials for: Proton pump inhibitor (PPI) medication

Total 73293 results

Shire

Completed

Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

United States, Czechia, Germany, Latvia, Poland, Romania
Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
KU Leuven

Completed

Acid Pocket: Position and Aspiration

Healthy Volunteers | Barrett Esophagus | GERD - PPI Responders | GERD - PPI Non-responders

Belgium
Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
HaEmek Medical Center, Israel

Completed

Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration

Schizophrenia | Medication Adherence | Inhibition (Psychology)

Israel
Medical University of Graz

Completed

Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors

Patients on Long-term Proton Pump Inhibitor Therapy

Austria
Novartis

Completed

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
AstraZeneca

Completed

Drug Interaction Study Between AZD3355 and Nexium

Gastroesophageal Reflux Disease

Sweden
Central Hospital, Nancy, France

Not yet recruiting

Evaluation of the "Pupillary Pain Index" in Neurological Prognosis After Cardiac Arrest (CAPPI)

Cardiac Arrest | Anoxic Brain Injury | Post-Anoxic Coma
Yonsei University

Completed

Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial

Chronic Cough Caused by Gastroesophageal Reflux

Korea, Republic of
Centre Hospitalier Universitaire Dijon

Completed

the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections. (UTOPIE)

Community Infections

France
PRAECIS Pharmaceuticals Inc.

Terminated

Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors

Solid Tumors | Non-Hodgkin's Lymphoma,

United States
Medical University of Graz

Completed

The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

Gastroesophageal Reflux

Austria
Meridian Bioscience, Inc.
Rabin Medical Center

Completed

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

Helicobacter Pylori Infection

Israel
Chinese University of Hong Kong

Completed

ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

Upper Gastrointestinal Bleeding

Hong Kong, Japan
PRAECIS Pharmaceuticals Inc.

Completed

Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

Primary carE PPi dEprescRibing Trial (PEPPER)

Dyspepsia | Heartburn | Reflux

Belgium
VA Office of Research and Development
VHA Pharmacy Benefits Management Services VA Center For Medication Safety

Completed

Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)

Proton Pump Inhibitors

United States
Ironwood Pharmaceuticals, Inc.

Terminated

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

Canada, United States
University Hospital, Basel, Switzerland

Recruiting

Smartphone App-assisted PPI (PIPPI)

Dyspepsia | Heartburn

Switzerland
Università degli Studi di Ferrara

Unknown

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata (GENIOUS)

Coronary Stenting

Italy
AstraZeneca

Completed

PPI Sequencing Study

Gastro-Oesophageal Reflux Disease

United Kingdom
Al-Azhar University

Not yet recruiting

Minimally Invasive Scrotal Incision for Penile Prosthesis Implantation, Novel Technique. (PPI)

Penile Prosthesis Infection | Penile Prosthesis; Complications, Infection or Inflammation
University Hospital, Caen

Completed

Delirium Related to Proton Pump Inhibitors Use

Delirium | Hyponatremia | Proton Pump Inhibitor Adverse Reaction

France
Federico II University
University of Catanzaro; Ospedale Nuovo Regina Margherita di Roma Dr. Salvatore...

Completed

Proton Pump Inhibitors and Gastrointestinal Symptoms

Gastrointestinal Symptoms | Small Intestinal Overgrowth

Italy
PRAECIS Pharmaceuticals Inc.

Completed

Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease

Alzheimer's Disease

United States
University of Roma La Sapienza

Unknown

PPI Therapy Impact on GERD After Sleeve Gastrectomy

Gastro Esophageal Reflux | Bariatric Surgery Candidate | Barrett Esophagus

Italy
Nantes University Hospital

Completed

Efficacy of a Multi-faceted Intervention to Deprescribe Proton Pump Inhibitors (PPI) in Primary Care: a Population-based, Pragmatic, Cluster-randomized Controlled Trial. (DeprescrIPP)

Proton Pump Inhibitors | Deprescription

France
Rabin Medical Center

Withdrawn

Gastric Acid Rebound Secretion Measured by Alkaline Tide

Condition Measuring Alkaline Tide and Filling Symptoms' Questionnaire After Abrupt or Gradual Step Down Cessation of PPI
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
The Catholic University of Korea

Unknown

Sublingual Administration of PPI

Gastric or Duodenal Ulcer

Korea, Republic of
University of Arizona
Janssen Pharmaceutica N.V., Belgium; Southern Arizona VA Health Care System

Completed

Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)

Gastroesophageal Reflux Disease

United States
University of Florida
Bristol-Myers Squibb; Sanofi

Completed

PPI and Clopidogrel Response

Drug Interaction

United States
Pfizer

Terminated

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Brazil, Germany, Korea, Republic of, Belgium, Spain, Slovakia, France
KK Women's and Children's Hospital

Recruiting

Integrated Psychological Program for Management of Postnatal Depression and Persistent Postpartum Pain After Childbirth (CODEPAD-II)

Depression, Postpartum

Singapore
Duke University

Recruiting

Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Novartis

Completed

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
University of Monastir

Recruiting

Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

Dyspepsia

Tunisia
Novartis

Completed

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

Dyspepsia

United States
Nemours Children's Clinic

Completed

Implementation of PPI Medication PGX Testing (PGX)

Gastroesophageal Reflux

United States
Samsung Medical Center

Recruiting

Emulation of Randomized Clinical Trial in Cardiovascular Disease (RCT-BigData)

Myocardial Infarction | Coronary Artery Disease

Korea, Republic of
Yonsei University

Completed

Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease

Non-erosive Gatroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Esomeprazole in PPI Failures - IMPROVE

Gastroesophageal Reflux Disease

Sweden
Ironwood Pharmaceuticals, Inc.

Completed

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

United States, Canada
King Saud University

Completed

Prophylaxis for Aspiration of Gastric Contents.

Pulmonary Aspiration of Gastric Contents
University Hospital, Strasbourg, France

Completed

Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age (Etaliepre-IPP)

Peptic Ulcer Disease

France
Universitaire Ziekenhuizen KU Leuven

Recruiting

Neuro-immune Interactions and PPI

Functional Dyspepsia

Belgium
AstraZeneca
UMC Utrecht

Completed

PPI Test in GP Patients

GERD

Netherlands
EndoGastric Solutions

Completed

The EndoGastric Solutions TEMPO Trial (TEMPO)

Gastroesophageal Reflux Disease (GERD)

United States
National Science Council, Taiwan

Completed

EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding (EVL)

Bleeding | Esophageal Varices

Search clinical trials for: Proton pump inhibitor (PPI) medication

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations